Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Acne lesions start with changes in hair follicles and increase in inflammation, suggesting a cycle that could affect treatment strategies.

Nickel, cobalt, balsam of Peru, fragrance mix, carba mix, and propylene glycol are common allergens causing scalp contact dermatitis.

Most skin changes during pregnancy are harmless and moles don't significantly change, but many women experience pigmentation changes due to hormones and sun exposure.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

Stromal cells in melanoma promote tumor growth and spread.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Awareness and better treatment of Demodex mites can improve health and quality of life.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Alopecia areata may lead to hearing loss.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

PRP might help with hair growth and skin rejuvenation, but more research is needed to prove its effectiveness.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

Trichoscopy is a reliable, non-invasive tool for diagnosing scalp alopecias.

Vascular endothelial cells may significantly influence skin stem cells, but more research is needed.

Experts created guidelines to better diagnose and treat uncommon fungal skin infections.

Mesotherapy might help with hair growth in androgenic alopecia, but more research is needed.

Oral minoxidil improved hair loss more than oral dutasteride.

Triamcinolone acetonide is more effective than cryotherapy for hair regrowth in alopecia areata but has different side effects.

Accurate diagnosis is crucial for effectively treating severe alopecia and related symptoms.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Topical treatments like AHAs, BHAs, and urea may help keratosis pilaris, but evidence is limited.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.